CombinedX (CX) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
13 Jun, 2025Executive summary
Revenue grew 27.5% year-over-year to 196.0 MSEK in Q3 2024, but organic growth was -2.1% due to a weak market and delayed customer projects.
Adjusted EBIT fell to 6.0 MSEK from 9.7 MSEK, with a margin of 3.1% versus 6.3% last year, reflecting lower utilization and increased personnel costs.
Strategic mergers and divestments, including combining Aspire with Ninetech and selling Borlänge operations, aim to improve margins and reduce exposure to weak segments.
CombinedX now consists of six specialist subsidiaries, with plans to expand to eight leading brands by 2028.
No clear signs of market recovery; expectations for improvement by end of 2024 are now uncertain.
Financial highlights
Q3 2024 revenue: 196.0 MSEK (153.7 MSEK in Q3 2023), growth 27.5%; organic growth -2.1%.
Adjusted EBIT: 6.0 MSEK (Q3 2023: 9.7 MSEK); margin 3.1% (Q3 2023: 6.3%).
Q3 net income: 3.7 MSEK (14.4 MSEK); EPS 0.21 (0.84) before dilution.
Cash flow from operations in Q3: 17.2 MSEK (-7.3 MSEK); cash position at period end: 92.8 MSEK.
LTM revenue: 882.5 MSEK; LTM adjusted EBIT margin: 8.0%.
Outlook and guidance
Market remains weak with no clear turnaround; delayed project starts and continued low utilization expected to impact profitability.
Management expects improved EBIT margin in 2025 following recent structural changes.
Strategic focus on consolidating specialist subsidiaries and reducing exposure to underperforming segments.
Long-term targets: EBIT margin ≥10%, organic growth above IT consulting market, sales ≥1 billion SEK by 2025, net debt/EBITDA ≤2x.
Latest events from CombinedX
- Record revenue, margin gains, and acquisitions drive a strategic shift to specialist brands.CX
Q4 202511 Feb 2026 - Strong revenue growth offset by sharply lower margins amid integration and market challenges.CX
Q2 202428 Jan 2026 - Q3 2025 saw higher margins and revenue, driven by acquisitions despite negative organic growth.CX
Q3 202524 Oct 2025 - Revenue declined and margins improved, with acquisitions supporting strategic growth.CX
Q2 202517 Jul 2025 - Q1 2025 saw 6.5% revenue growth and resilient margins despite market challenges.CX
Q1 20256 Jun 2025 - Revenue surged but organic growth and margins fell; acquisitions set up 2025 recovery.CX
Q4 20245 Jun 2025